Skip to content

Preface to the special issue “Psychedelics and Neurochemistry”

C. Nichols, D. Nichols

Journal of Neurochemistry June 14, 2022 DOI: 10.1111/jnc.15651 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Editorial Peer reviewed
Key points The authors state that psychedelics have demonstrated profound and durable therapeutic potential for several psychiatric disorders, including depression, anxiety, and substance use disorders, and they present a special issue spanning basic molecular and cellular science through clinical reviews, with particular attention to the serotonin 5-HT2A receptor's role in healthy and diseased brain function.

Abstract

Psychedelics are a relatively recent field of research that had not gained much support half a century ago, yet it developed into a much acknowledged, highly relevant field that extends to many people's lives. Psychedelics have demonstrated profound and durable therapeutic potential for the treatment of several psychiatric disorders including depression, anxiety, and substance use disorders, among others. In this special issue, basic science of psychedelics is reviewed with respect to fundamental cellular, molecular, and genetic mechanisms, all the way up to the human systems level with clinical reviews. We hope the articles, authored by leading scientists in their field, will help to understand better the role of the serotonin 5‐HT2A receptor in particular in healthy and diseased brain function.

Citations in the library

Explore topics